Loading INDV charts…
May we use analytics cookies to see how vpside is used, including anonymous session recordings? Accepting also loads the price chart, which sets its own cookies. Essential cookies are always on. Privacy
Loading INDV comparable companies…
| INDVIndivior Pharmaceuticals, Inc.(opens in a new tab) | $4.32B | $1.37B | — | 85.0% | 40.6% | 3.14× | 9.9× |
|---|---|---|---|---|---|---|---|
| SRPTSarepta Therapeutics, Inc.(opens in a new tab) | $1.96B | $1.40B | −36.2% | 55.0% | −10.2% | 1.40× | — |
| MDGLMadrigal Pharmaceuticals, Inc.(opens in a new tab) | $12.54B | $1.28B | +149.0% | — | −25.1% | 9.77× | — |
| LKFTLakefront Biotherapeutics NV(opens in a new tab) | $2.13B | $1.26B | +321.6% | 97.3% | 26.5% | 1.69× | 5.9× |
| PAHCPhibro Animal Health Corp.(opens in a new tab) | $1.59B | $1.52B | +17.1% | 33.8% | 12.8% | 1.05× | 15.9× |
| Medianpeers, excl. INDV | $2.04B | $1.34B | +83.1% | 55.0% | 1.3% | 1.55× | 10.9× |